Reduced quality of clot formation with gelatin-based plasma substitutes

British Journal of Anaesthesia

Volumn 80, Issue 2, 1998, Pages 204-207

  Mardel, S N ^a,f   Saunders, F M ^a   Allen, H ^a   Menezes, G ^b   Edwards, C M ^d   Ollerenshaw, L ^a   Baddeley, D ^e   Kennedy, A ^c   Ibbotson, R M ^a  

^a UNIVERSITY HOSPITALS OF NORTH MIDLANDS NHS TRUST   (United Kingdom)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

^c NHS GRAMPIAN   (United Kingdom)

^d UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST   (United Kingdom)

^e ROYAL CORNWALL HOSPITALS NHS TRUST   (United Kingdom)

^f FURNESS GENERAL HOSPITAL   (United Kingdom)

Author keywords

Blood, coagulation; Blood, colloids; Blood, haemostasis; Blood, replacement; Fluids, i.v.; Measurement techniques, thrombelastography

Indexed keywords

FIBRIN; GELATIN SUCCINATE; PLASMA SUBSTITUTE; POLYGELINE;

ARTICLE; BLOOD CLOT; BLOOD CLOTTING; COLLOID; CONTROLLED STUDY; CRYSTALLOID; HUMAN; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; SHEAR STRESS; THROMBOELASTOGRAPHY;

EID: 0031915208     PISSN: 00070912     EISSN: None     Source Type: Journal    
DOI: 10.1093/bja/80.2.204     Document Type: Article

References (16)

1. Heene DL, Lasch HG. The effect of plasma substitutes on the haemostatic mechanism. Bibliotheca Haematologica 1969; 33: 428-433.
2. Muller KH, Scholz HJ, Barthel R. Blutgerinnungsveranderungen durch wiederholte infusionen von Plasmasubstituten. Geburtshilfe und Frauenheilkunde 1969; 29: 1095-1110.
3. Froeschlin W. The treatment of shock with Haemaccel, a new plasma expander. Deutsche Medizinische Wochenschrift. 1962; 87: 811-819.
4. Harke H, Thoenies R, Margraf I, Momsen W. Der Einflub verschiedener Plasmersatzmittel auf Gerinnungssystem und Thrombocytenfunktion wahrend und nach operativen Eingriffen. Anaesthesist 1976; 25: 366-373.
5. Mardel SN, Saunders F, Ollerenshaw L, Edwards C, Baddeley DT. Reduced quality of in-vitro clot formation with gelatin based substitutes. Lancet 1996; 347: 825.
6. Dacie JV, Lewis SM. Practical Haematology, 5th Edn. Edinburgh: Churchill Livingstone, 1975.
7. De Nicola P. Thrombelastography. Illinois: Springfield, 1957.
8. Ts'ao CH, Krajewski DV. Effect of dextran on platelet activation by polymerising fibrin. American Journal of Pathology 1982; 106: 1-7.
9. Aberg M, Hedner U, Bergentz SE. Effect of dextran on factor VIII (antihemophilic factor) and platelet function. Annals of Surgery 1979; 189: 243.
10. Sanfelippo MJ, Suberviola PD, Geimer NF. Development of a von Willebrand-like syndrome after prolonged use of hydroxethyl starch. American Journal of Clinical Pathology 1987; 88: 653.
11. Stibbe J, Kirby EP. Inhibition of ristocetin-induced platelet aggregation by Haemaccel. British Medical Journal. 1975; 2: 750-751.
12. Ruttmann TG, James MFM, Viljoen JF. Haemodilution induces a hypercoagulable state. British Journal of Anaesthesia 1996; 76: 412-414.
13. Kim HW, Stubdal H, Greenburg AG. Coagulation dynamics after hemodilution with polyhemoglobin. Surgery, Gynecology and Obstetrics 1992; 175: 219-226.
14. Chow TW, McIntire LV, Peterson DM. Importance of plasma fibronectin in determining PFP and PRP clot mechanical properties. Thrombosis Research 1983; 29: 243-248.
15. Engvall E, Ruo-Slahti E, Miller VJ. Affinity of fibronectin to collagens of different genetic types and fibrinogen. Journal of Experimental Medicine 1978; 147: 1584.
16. Brodin B, Hesselvik F, von-Schenck H. Decrease of plasma fibronectin concentration following infusion of a gelatin based plasma substitute in man. Scandinavian Journal of Clinical Laboratory Investigation 1984; 44: 529-533.